Ind-Swift Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

107.11

+2.10 (+2.00%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

107.11

+2.10 (+2.00%)
16:02 Dec 20

Quality

62/100
High Financial Strength

Valuation

77/100
Affordable Valuation

Technical

44/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	891.34	1038.73	1207.31	1280.9	725.97
Operating Expenses +	708.52	842.35	978.11	1026.7	733.53
Raw Material	453.92	566.06	667.92	624.39	469.66
Increase Decrease in Cost	-2.48	-39.47	-12.34	37.07	34.53
Other Manufacturing Expense	64.79	84.14	111.28	100.68	0
Employee Cost	106.55	114.35	135.84	152.81	88.22
Miscellaneous Expenses	85.74	119.39	96.33	162.41	141.12
Operating Profit	182.82	196.38	229.2	254.2	-7.56
Other Income	22.7	42.71	33.5	45.37	56.51
Depreciation	87.29	131.04	57.36	53.3	26.7
Interest	100.22	95.53	92.17	51.1	10.16
Profit before tax and exceptio..	18.01	12.53	113.17	195.17	12.09
Exceptional Items	0	0	-26.65	386.59	386.59
PBT	18.01	12.53	86.52	581.76	-374.5
Provision for Taxation	21.16	14.68	38.69	160.31	138.87
Net Profit	-3.15	-2.15	47.83	421.45	259.81
NET Profit after MI	-3.15	-2.15	47.6	420.96	259.59
EPS	-0.53	-0.36	8.1	71.24	43.94
Operating Profit Margin (%)	20.51	18.91	18.98	19.85	-1.04
Net Profit Margin (%)	-0.35	-0.21	3.94	32.86	35.76

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	42.00	42.00	42.00	42.00	42.00
FII	0.60	1.30	0.30	0.30	0.20
MF	0.00	0.00	0.00	0.00	0.00
Public	56.40	55.80	49.70	39.00	38.30
Others	0.00	0.00	0.00	0.00	0.00
Others	1.00	0.90	8.00	18.70	19.50